|
|
|
Volumn 27, Issue 9, 2008, Pages 956-961
|
|
Prognosis analysis of 83 cases of cervical adenosquamous carcinoma
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACLARUBICIN;
ANTINEOPLASTIC AGENT;
CAP THERAPY PROTOCOL;
CISPLATIN;
PEPLEOMYCIN;
ADENOSQUAMOUS CARCINOMA;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
ADULT;
AGED;
ARTICLE;
BRACHYTHERAPY;
CANCER INVASION;
CANCER STAGING;
DISEASE FREE SURVIVAL;
FEMALE;
FOLLOW UP;
HUMAN;
HYSTERECTOMY;
LYMPH NODE METASTASIS;
METHODOLOGY;
MIDDLE AGED;
PATHOLOGY;
PROGNOSIS;
PROPORTIONAL HAZARDS MODEL;
SURVIVAL RATE;
TUMOR RECURRENCE;
TUMOR VOLUME;
UTERINE CERVIX TUMOR;
ACLARUBICIN;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BRACHYTHERAPY;
CARCINOMA, ADENOSQUAMOUS;
CHEMOTHERAPY, ADJUVANT;
CISPLATIN;
DISEASE-FREE SURVIVAL;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
HYSTERECTOMY;
LYMPHATIC METASTASIS;
MIDDLE AGED;
NEOPLASM INVASIVENESS;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
PEPLOMYCIN;
PROGNOSIS;
PROPORTIONAL HAZARDS MODELS;
RADIOTHERAPY, ADJUVANT;
SURVIVAL RATE;
TUMOR BURDEN;
UTERINE CERVICAL NEOPLASMS;
|
|
EID: 77956092661
PISSN: 1000467X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|
